Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in HER-2 Negative Metastatic Breast Cancer
NCT01693549Phase 2Completed
- Sponsor
- HeCOG
- Start
- Sep 2012
- Primary completion
- Jul 2017
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel in breast cancer, sponsored by HeCOG. Started Sep 2012; status: completed.
02
Drugs
cabazitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01693549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01693549.